|
HS Code |
695522 |
| Product Name | 6-Bromo-2,3-Difluorophenol |
| Cas Number | 885273-15-2 |
| Molecular Formula | C6H3BrF2O |
| Molecular Weight | 208.99 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 98% |
| Structure | Bromine at position 6, fluorines at positions 2 and 3, hydroxyl group at position 1 on benzene ring |
| Synonyms | 2,3-Difluoro-6-bromophenol |
| Smiles | C1=C(C=C(C(=C1F)F)Br)O |
As an accredited 6-Bromo-2,3-Difluorophenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of 6-Bromo-2,3-Difluorophenol, sealed with a screw cap and safety labeling. |
| Shipping | 6-Bromo-2,3-Difluorophenol is shipped in tightly sealed containers, protected from light and moisture. It is transported following standard regulations for hazardous chemicals, ensuring proper labeling and documentation. The packaging prevents leaks and contamination, while handling complies with safety guidelines to protect personnel and the environment during transit. |
| Storage | **6-Bromo-2,3-difluorophenol** should be stored in a tightly sealed container, away from direct sunlight and sources of ignition. Keep it in a cool, dry, well-ventilated area, separated from incompatible substances such as strong oxidizing agents and bases. Store at room temperature, and ensure proper chemical labeling and access to safety data sheets (SDS) for safe handling and emergency reference. |
Competitive 6-Bromo-2,3-Difluorophenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of 6-Bromo-2,3-Difluorophenol we produce carries the marks of our careful stewardship and direct engagement with the realities of large-scale organic synthesis. For years, requests for halogenated intermediates with high positional selectivity have surfaced in conversations with formulation chemists and process engineers. We respond to this signal by building our own production routes for specialty phenols, especially those serving modern pharmaceutical, agrochemical, and fine chemical R&D pipelines. This compound—CAS number 262550-02-9, molecular formula C6H3BrF2O—embodies our effort to meet increasing demand for multi-functional, electronically unique phenols built for high-complexity molecule construction.
Our knowledge stems from years spent managing temperature and pressure inside glass-lined kettles, tuning stepwise additions to favor specific substitution patterns, ensuring each run finishes over the same narrow melting point. No one wants uncertainty when downstream coupling, protection, or derivatization rides on a single phenol’s position or purity. The 6-Bromo-2,3-Difluorophenol we ship is the same material our R&D teams use during our own process scale-ups, sourced through a route we have optimized for selectivity at the bromo and fluoro sites. Control over critical factors—reagent purity, residence time, stirring dynamics—reduces the presence of isomeric byproducts and boosts the yield of the correct regioisomer to a dependable range. Customers have told us, rather plainly, that this decreases wasted hours in purification, so production leaves nothing to chance that can be avoided.
6-Bromo-2,3-Difluorophenol stands out during electrophilic aromatic substitution and cross-coupling strategies, especially where electron-withdrawing effects shape reactivity. The electron-rich hydroxyl and the two tightly arranged fluorines help enable and direct selectivity in Suzuki and Buchwald couplings, and the bromine gives well-balanced leaving group activity in the context of Ullmann-type and transition-metal-catalyzed reactions. Compared with simple mono- or difluorophenols, this particular scaffold allows precise tailoring of electronic structure in the final product. Our customers often report improved yields and cleaner profiles when using our material as a starting point for expressed-function molecules: kinase inhibitors, non-naturally substituted agrochemicals, and charge-sensitive monomers for specialty polymers.
We maintain air exclusion and moisture control throughout production and packaging, not just to satisfy best practices, but to protect the phenol from trace hydrolysis and light-driven side reactions common to aromatic substrates with strong halogenation. Our floor teams point out how certain process modifications reduce not just major contaminants but stubborn, low-level impurities that can complicate life in a chemist’s hood. Sometimes, the solution to a problem has nothing to do with the recipe on the batch sheet—say, slightly altering agitation at the bromo introduction, or recognizing subtle temperature reversibility during wash steps before crystallization. The finished product reflects dozens of such incremental improvements developed over years of close observation.
Fluorinated aromatics have always played a definitive part in the optimization of pharmaceutical candidates. Fluorine atoms on an aromatic ring can dramatically alter both the metabolic stability and the hydrogen-bonding pattern of a molecule. The difluoro configuration here proves especially valuable for fine-tuning acidity and reactivity during subsequent transformations. Adding bromine in the six position changes the steric and electronic characteristics even further, pushing this phenol into a class apart from the more commonly encountered 2,4- or 3,5-substituted isomers. Working at the manufacturing level, we pay attention not just to gross impurity counts, but to the trace isomer ratios that directly impact the efficiency of subsequent installations, be these biaryl couplings or the formation of benzoxazoles and other heterocycles.
Any manufacturer who spends time talking directly to research chemists knows that small differences in initial material can cascade into day-consuming troubleshooting in the lab. From our perspective, anecdotal feedback is as important as regulatory filings. We have modified our crystallization and drying steps based on real-world experiences: for example, recognizing a tendency toward clumping at higher relative humidity, or learning from end-users which solvent traces are most disruptive to catalysis screens. One round of customer input highlighted the impact of microcrystalline fraction on rate-limited reactions in high-throughput screening. In response, we adopted additional fine-filtration and drying steps, resulting in a tighter particle size distribution. These changes come from two-way exchange between our production teams and the people who use our material on a daily basis.
A laboratory with the choice between ordinary halogenated phenols and our 6-Bromo-2,3-Difluorophenol faces several clear differences. Other mixed halide phenols may offer brute functionality—bromine for reactivity, fluorine for stability—but they usually lack this unique substitution pattern. Many companies, given limited demand, offer products sourced or repackaged rather than manufactured directly, leading to lot-to-lot variation, higher isomer content, or additional purification steps downstream. We know the upstream synthesis and control each point of variability ourselves, ensuring what arrives in your bottle matches what we use batch after batch. For chemical methodologies that require tight control—such as photochemically active building blocks or intermediates where heavy metal contamination matters—this kind of vertical control closes gaps that third-party material often leaves open.
Our involvement includes regular dialog with regulatory agencies and internal quality assurance teams. Direct manufacturing responsibility makes us accountable for traceability and the fulfillment of modern documentation standards. Our quality control lab monitors every outgoing batch with NMR, GC, HPLC, and elemental analysis, pushing detection limits below standard cutoffs. Results rarely vary across lots, which speeds up customer intake and validation. We invest in high-purity solvents and ultrapure reagents where trace heavy metals, halide salts, and water can impact analytical readings. Strict batch record-keeping means a customer can trace any discrepancy back to its origin. This level of accountability comes from being the one who actually makes, not just distributes, every kilogram that goes out the door.
Our customers have described pain points in both small-scale screening and multi-kilo synthesis. For coupling reactions, unpredictable isomer ratios or residual metal impurities can ruin selectivity or poison catalysts, forcing frustrating purification cycles. To solve this, we focus on process closure: we trap and remove byproducts as early as possible, invest in in-line monitoring, and collaborate with our analytics group for real-time feedback. We do not rely on only post-run testing; we build quality into the process from the start. This approach has reduced repeat reports of failed couplings or contamination issues, saving time for both our team and those who rely on our intermediates to move projects forward under pressurized development timelines.
Having followed our own material from raw chemical feedstock to finished bottle, we see how one small change upstream can ripple out across entire research projects. We address real-world issues that traders and brokers often cannot—such as custom packaging needs, direct documentation of synthesis, and rapid troubleshooting for atypical impurity profiles. In some cases, we field phone calls directly from scale-up groups or synthetic teams, investigating and addressing questions about lot performance, which would be impossible if we did not control every stage of production ourselves. This reality shapes our standard of service and helps us maintain strong, trust-based relationships with the chemists we serve.
Handling strong brominating and fluorinating agents at scale brings its own set of environmental, health, and safety hurdles. Our plant invests in containment technology, real-time leakage detection, and continuous air monitoring to minimize any risk to operators or surroundings. Our containment procedures have tightened over the years, thanks to collaboration with safety consultants and feedback from our operations team. We now reclaim solvent streams and neutralize waste inline to keep emissions low and to meet the latest legal expectations for specialty chemical manufacturing. These investments do not simply answer to compliance—they ensure the continuity and reliability of supply, even under stricter regulatory oversight.
Chemists continue to push the boundaries of complexity, and we frequently adjust targets on purity, hydration, and packaging to match the latest synthetic demands. Six months ago, feedback from an agrochemical partner led us to monitor trace halide counts below one part per million—a target not widely pursued outside pharma. As new catalytic transformations gain traction, the reduced reactivity windows and growing sophistication of building blocks make batch-to-batch predictability even more crucial than before. Our direct-to-lab model stands up to scrutiny because it is built on open technical dialogue and a willingness to adapt existing protocol, not rigid adherence to legacy procedures.
Modern synthesis relies more than ever on reliable, well-documented starting materials. 6-Bromo-2,3-Difluorophenol has grown in importance with the advance of combinatorial chemistry and high-throughput screening. We build for this future by keeping documentation current, maintaining internal standards for analytical and process rigor, and working alongside our customer base to foresee where next-generation requirements may trend. Continuous exchanges between our process chemists and external formulation teams help us anticipate potential new reactions or regulatory changes, so our material arrives ready for tomorrow’s challenges, not just today’s.
We focus on real-world usability beyond the technical datasheet. This means every bottle ships with a batch record—a log of conditions, analytical summaries, and process notes—that speaks plainly to chemists running parallel screens or process validations. If we encounter a process drift or identify a novel side reaction, we communicate this to customers directly. We know that timely information sharing can prevent setbacks across multiple research groups at once. Our commitment manifests through these conversations, not just through compliance with the letter of the law or an out-of-date specification sheet.
Direct input from the field sustains our progress. End-users send queries about solubility quirks, shelf life, or compatibility with new coupling methodologies. With direct production oversight, we execute rapid trials or ship technical samples for quick testing. Each iteration changes the way we build and package subsequent lots. Chemical manufacturing, at its best, works as a conversation between makers and users. Our 6-Bromo-2,3-Difluorophenol represents this approach: adaptable, reliable, made with a clear understanding of its impact at the bench and in the production suite alike.
What enters your workspace is not just a regulated commodity—it is a carefully engineered intermediate developed by people who take pride in the continuity between their work and your scientific progress. We make, test, and ship 6-Bromo-2,3-Difluorophenol not as faceless units but as collaborators invested in successful outcomes, batch after batch. Production here serves not only specifications, but the daily rhythm of complex synthesis. Chemistry, in the end, remains a discipline grounded in attention, rigor, and shared knowledge. We bring that mindset each time we prepare and deliver this phenol, striving for a standard that adds to a project rather than distracts from it.